Volume 11, Issue 2 (2025)
Pharm Biomed Res 2025, 11(2): 125-138 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Imam-Fulani A O, Shuaib A O, Olajide L O, Afolabi H O, Inyang J, Onoshi O O, et al . Caffeine Modulates Oxidative Stress and Neuroinflammation in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease in Female Mice. Pharm Biomed Res 2025; 11 (2) :125-138
URL: http://pbr.mazums.ac.ir/article-1-667-en.html
URL: http://pbr.mazums.ac.ir/article-1-667-en.html
Aminat Omolola Imam-Fulani *1 
, Abdulrahman Olanrewaju Shuaib2 , Lateefah Omotoyosi Olajide3 , Halimat Oluwakemi Afolabi3 , Jerry Inyang3 , Oluwadamilola Onoshi Onoshi3 , Taofeekat Temitope Ogunsesan3 , Oyindamola Bisola Adekunle3 , Taiwo Elijah Eso3 , Oluwaseyi Deborah Babatunde3 , Edwin Ayolola Makanjuola3 , Olamilekan Abdulfatai Alimi3 , Hafeez Ajibola Olorunoje3 , Kamaldeen Olalekan Sanusi4
, Abdulrahman Olanrewaju Shuaib2 , Lateefah Omotoyosi Olajide3 , Halimat Oluwakemi Afolabi3 , Jerry Inyang3 , Oluwadamilola Onoshi Onoshi3 , Taofeekat Temitope Ogunsesan3 , Oyindamola Bisola Adekunle3 , Taiwo Elijah Eso3 , Oluwaseyi Deborah Babatunde3 , Edwin Ayolola Makanjuola3 , Olamilekan Abdulfatai Alimi3 , Hafeez Ajibola Olorunoje3 , Kamaldeen Olalekan Sanusi4
1- Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria. & Department of Neuroscience, Medical School, University of Minnesota, Minneapolis, United States.
2- Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria. & Department of Human Physiology, Faculty of Basic Medical Sciences, Al-Hikmah University, Ilorin, Nigeria.
3- Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
4- Department of Human Physiology, Faculty of Basic Medical Sciences, Al-Hikmah University, Ilorin, Nigeria.
2- Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria. & Department of Human Physiology, Faculty of Basic Medical Sciences, Al-Hikmah University, Ilorin, Nigeria.
3- Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
4- Department of Human Physiology, Faculty of Basic Medical Sciences, Al-Hikmah University, Ilorin, Nigeria.
Abstract: (80 Views)
Background: Parkinson’s disease (PD) is a neurodegenerative disorder marked by dopaminergic neuron loss, oxidative stress, and neuroinflammation, leading to progressive motor dysfunction. Current treatments provide symptomatic relief but do not halt disease progression. Caffeine, a widely consumed neurostimulant, has been linked to a reduced risk of PD and possesses antioxidant and anti-inflammatory properties.
Objectives: We investigated the effects of caffeine on motor performance, biochemical markers, and immunohistochemical changes in an MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced model of PD in female Swiss mice.
Methods: Twenty-five female mice were used, with 20 injected intraperitoneally (ip) with MPTP to induce PD. The mice were divided into five groups (n=5): Healthy controls, MPTP-induced PD, L-Dopa, 10 mg/kg caffeine, and 5 mg/kg caffeine for three weeks. Behavioral tests, including the pole test, beam test, and open field maze assessed motor activity and anxiety. Brain, liver, and heart tissues were analyzed for antioxidant, inflammatory, and oxidative stress markers. Brain tissues were also examined for immunohistochemistry, assessing microglial activation, TH, and α-synuclein to measure dopamine loss.
Results: Caffeine administration significantly (P<0.05) improved motor performance and decreased anxiety compared to MPTP-induced mice. Biochemical analyses of brain tissue showed that caffeine enhanced antioxidant activity by increasing the levels of catalase and glutathione while decreasing malondialdehyde (MDA), a marker of oxidative stress. Caffeine also significantly reduced the levels of pro-inflammatory cytokines, TNF-α, and IL-1α in the brain tissue, indicating an anti-inflammatory effect. Serum biochemical analyses indicated increased superoxide dismutase (SOD) levels, elevated catalase activity, and reduced MDA levels in caffeine-treated groups. Immunohistochemical analysis revealed a significant reduction in the expression of α-synuclein and microglial activation and preservation of TH-positive dopaminergic neurons in the substantia nigra following caffeine treatment.
Conclusion: Caffeine exerts protective effects against motor dysfunction, oxidative stress, and neuroinflammation in an MPTP-induced model of PD, highlighting its potential as a therapeutic agent for managing PD.
Objectives: We investigated the effects of caffeine on motor performance, biochemical markers, and immunohistochemical changes in an MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced model of PD in female Swiss mice.
Methods: Twenty-five female mice were used, with 20 injected intraperitoneally (ip) with MPTP to induce PD. The mice were divided into five groups (n=5): Healthy controls, MPTP-induced PD, L-Dopa, 10 mg/kg caffeine, and 5 mg/kg caffeine for three weeks. Behavioral tests, including the pole test, beam test, and open field maze assessed motor activity and anxiety. Brain, liver, and heart tissues were analyzed for antioxidant, inflammatory, and oxidative stress markers. Brain tissues were also examined for immunohistochemistry, assessing microglial activation, TH, and α-synuclein to measure dopamine loss.
Results: Caffeine administration significantly (P<0.05) improved motor performance and decreased anxiety compared to MPTP-induced mice. Biochemical analyses of brain tissue showed that caffeine enhanced antioxidant activity by increasing the levels of catalase and glutathione while decreasing malondialdehyde (MDA), a marker of oxidative stress. Caffeine also significantly reduced the levels of pro-inflammatory cytokines, TNF-α, and IL-1α in the brain tissue, indicating an anti-inflammatory effect. Serum biochemical analyses indicated increased superoxide dismutase (SOD) levels, elevated catalase activity, and reduced MDA levels in caffeine-treated groups. Immunohistochemical analysis revealed a significant reduction in the expression of α-synuclein and microglial activation and preservation of TH-positive dopaminergic neurons in the substantia nigra following caffeine treatment.
Conclusion: Caffeine exerts protective effects against motor dysfunction, oxidative stress, and neuroinflammation in an MPTP-induced model of PD, highlighting its potential as a therapeutic agent for managing PD.
Type of Study: Original Research |
Subject:
Cellular and Molecular Biology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
